S&P 500   4,567.43 (+0.50%)
DOW   35,737.49 (+0.17%)
QQQ   377.83 (+1.00%)
AAPL   148.82 (+0.09%)
MSFT   308.82 (-0.11%)
FB   326.39 (+0.55%)
GOOGL   2,755.58 (+0.15%)
TSLA   994.04 (+9.27%)
AMZN   3,330.94 (-0.14%)
NVDA   232.85 (+2.46%)
BABA   176.14 (-0.88%)
NIO   41.19 (+5.94%)
CGC   13.27 (-0.82%)
GE   105.62 (+1.51%)
AMD   123.22 (+2.84%)
MU   68.97 (+2.16%)
T   25.45 (-0.16%)
F   15.88 (-2.46%)
ACB   7.10 (+0.42%)
DIS   171.83 (+1.42%)
PFE   42.97 (-0.44%)
BA   211.98 (-0.46%)
AMC   37.31 (+1.94%)
S&P 500   4,567.43 (+0.50%)
DOW   35,737.49 (+0.17%)
QQQ   377.83 (+1.00%)
AAPL   148.82 (+0.09%)
MSFT   308.82 (-0.11%)
FB   326.39 (+0.55%)
GOOGL   2,755.58 (+0.15%)
TSLA   994.04 (+9.27%)
AMZN   3,330.94 (-0.14%)
NVDA   232.85 (+2.46%)
BABA   176.14 (-0.88%)
NIO   41.19 (+5.94%)
CGC   13.27 (-0.82%)
GE   105.62 (+1.51%)
AMD   123.22 (+2.84%)
MU   68.97 (+2.16%)
T   25.45 (-0.16%)
F   15.88 (-2.46%)
ACB   7.10 (+0.42%)
DIS   171.83 (+1.42%)
PFE   42.97 (-0.44%)
BA   211.98 (-0.46%)
AMC   37.31 (+1.94%)
S&P 500   4,567.43 (+0.50%)
DOW   35,737.49 (+0.17%)
QQQ   377.83 (+1.00%)
AAPL   148.82 (+0.09%)
MSFT   308.82 (-0.11%)
FB   326.39 (+0.55%)
GOOGL   2,755.58 (+0.15%)
TSLA   994.04 (+9.27%)
AMZN   3,330.94 (-0.14%)
NVDA   232.85 (+2.46%)
BABA   176.14 (-0.88%)
NIO   41.19 (+5.94%)
CGC   13.27 (-0.82%)
GE   105.62 (+1.51%)
AMD   123.22 (+2.84%)
MU   68.97 (+2.16%)
T   25.45 (-0.16%)
F   15.88 (-2.46%)
ACB   7.10 (+0.42%)
DIS   171.83 (+1.42%)
PFE   42.97 (-0.44%)
BA   211.98 (-0.46%)
AMC   37.31 (+1.94%)
S&P 500   4,567.43 (+0.50%)
DOW   35,737.49 (+0.17%)
QQQ   377.83 (+1.00%)
AAPL   148.82 (+0.09%)
MSFT   308.82 (-0.11%)
FB   326.39 (+0.55%)
GOOGL   2,755.58 (+0.15%)
TSLA   994.04 (+9.27%)
AMZN   3,330.94 (-0.14%)
NVDA   232.85 (+2.46%)
BABA   176.14 (-0.88%)
NIO   41.19 (+5.94%)
CGC   13.27 (-0.82%)
GE   105.62 (+1.51%)
AMD   123.22 (+2.84%)
MU   68.97 (+2.16%)
T   25.45 (-0.16%)
F   15.88 (-2.46%)
ACB   7.10 (+0.42%)
DIS   171.83 (+1.42%)
PFE   42.97 (-0.44%)
BA   211.98 (-0.46%)
AMC   37.31 (+1.94%)
OTCMKTS:ASPCF

Acerus Pharmaceuticals Short Interest Ratio and Short Volume

$0.03
0.00 (0.00 %)
(As of 10/22/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.03
$0.03
50-Day Range
$0.03
$0.04
52-Week Range
$0.02
$0.08
VolumeN/A
Average Volume26,393 shs
Market Capitalization$40.13 million
P/E RatioN/A
Dividend YieldN/A
Beta1.01

Acerus Pharmaceuticals (OTCMKTS:ASPCF) Short Interest Data

Current Short Volume90,000 shares
Previous Short Volume11,000 shares
Change Vs. Previous Month+718.18%
Dollar Volume Sold Short$2,430.00
Short Interest Ratio / Days to Cover5.2
Last Record DateSeptember, 30 2021
Outstanding Shares1,537,588,000 shares
Percentage of Shares Shorted0.01%
Today's Trading Volume0 shares
Average Trading Volume26,393 shares
Today's Volume Vs. Average-100.00%

Days to Cover Over Time

Percentage of Float Shorted Over Time

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Acerus Pharmaceuticals ?

Sign up to receive the latest short interest report for Acerus Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Acerus Pharmaceuticals (OTCMKTS:ASPCF) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/30/202190,000 shares $2,430.00 +718.2%N/A5.2 $0.03
9/15/202111,000 shares $424.60 -44.7%N/A0.8 $0.04
8/31/202119,900 shares $716.40 +5.9%N/A1.6 $0.04
8/13/202118,800 shares $695.60 +21.3%N/A1.4 $0.04
7/30/202115,500 shares $542.50 +80.2%N/A0.5 $0.04
7/15/20218,600 shares $345.72 -94.9%N/A0.9 $0.04
6/30/2021168,100 shares $5,984.36 -0.2%N/A3.2 $0.04
6/15/2021168,400 shares $5,776.12 -1.1%N/A19.6 $0.03
5/28/2021170,300 shares $6,113.77 +12.7%N/A12.6 $0.04
5/14/2021151,100 shares $5,474.96 +189.5%N/A5.9 $0.04
4/30/202152,200 shares $2,610.00 +239.0%N/A1.7 $0.05
4/15/202115,400 shares $616.00 +3,750.0%N/A0.2 $0.04
3/31/2021400 shares $20.00 -98.6%N/A0 $0.05
3/15/202128,400 shares $1,226.88 -32.2%N/A0.5 $0.04
2/26/202141,900 shares $1,646.67 +2,105.3%N/A0.9 $0.04
2/12/20211,900 shares $94.62 +533.3%N/A0 $0.05
1/29/2021300 shares $11.37 -96.9%N/A0 $0.04
1/15/202113,700 shares $424.70 -58.1%N/A1 $0.03
12/31/202014,100 shares $366.60 +2.9%N/A0.2 $0.03
12/15/202013,700 shares $349.35 -58.1%N/A1 $0.03
11/30/202032,700 shares $981.00 +39.7%N/A0.8 $0.03
11/15/202023,400 shares $425.88 +127.2%N/A1.3 $0.02
10/30/202010,300 shares $367.71 +22.6%N/A0.9 $0.04
10/15/20208,400 shares $420.00 +1,100.0%N/A0.5 $0.05
9/30/2020700 shares $28.91 No ChangeN/A0 $0.04

Acerus Pharmaceuticals (OTCMKTS:ASPCF) Short Interest FAQ













Acerus Pharmaceuticals (OTCMKTS:ASPCF) Short Interest Frequently Asked Questions

What is Acerus Pharmaceuticals' current short interest?

Short interest is the volume of Acerus Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of September 30th, traders have sold 90,000 shares of ASPCF short. Learn More on Acerus Pharmaceuticals' current short interest.

What is a good short interest ratio for Acerus Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Acerus Pharmaceuticals currently has a short interest ratio of 5.0. Learn More on a good short interest ratio for Acerus Pharmaceuticals

Is Acerus Pharmaceuticals' short interest increasing or decreasing?

Acerus Pharmaceuticals saw a increase in short interest in September. As of September 30th, there was short interest totaling 90,000 shares, an increase of 718.2% from the previous total of 11,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Acerus Pharmaceuticals' short interest compare to its competitors?

0.00% of Acerus Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Acerus Pharmaceuticals: Zynerba Pharmaceuticals, Inc. (4.70%), Adamis Pharmaceuticals Co. (0.00%), Anebulo Pharmaceuticals, Inc. (0.24%), Enlivex Therapeutics Ltd. (0.00%), Tiziana Life Sciences PLC (0.00%), Gemini Therapeutics, Inc. (9.17%), ObsEva SA (1.80%), Vascular Biogenics Ltd. (4.68%), Aptinyx Inc. (1.95%), and OptiNose, Inc. (9.45%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: S&P Global Inc. ($7.35 billion), Advanced Micro Devices, Inc. ($6.43 billion), Charter Communications, Inc. ($5.68 billion), Wayfair Inc. ($4.48 billion), Uber Technologies, Inc. ($3.77 billion), Canadian Pacific Railway Limited ($3.73 billion), Palo Alto Networks, Inc. ($3.10 billion), Zoom Video Communications, Inc. ($2.87 billion), Match Group, Inc. ($2.83 billion), and DoorDash, Inc. ($2.54 billion). View all of the most shorted stocks.

What does it mean to sell short Acerus Pharmaceuticals stock?

Short selling ASPCF is an investing strategy that aims to generate trading profit from Acerus Pharmaceuticals as its price is falling. To short Acerus Pharmaceuticals stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Acerus Pharmaceuticals will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Acerus Pharmaceuticals?

A short squeeze for Acerus Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ASPCF, which in turn drives the price of the stock up even further.

How often is Acerus Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ASPCF, twice per month. The most recent reporting period available is September, 30 2021.



This page was last updated on 10/25/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.